INMD Stock Analysis: Buy, Sell, or Hold?
INMD - InMode Ltd. Ordinary Shares
$13.29
0.08 (0.61%)
▲
5d:
-2.06%
30d:
-3.9%
90d:
-3.2%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: INMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.54
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$11.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $13.29, which is considered oversold relative to its 30-day fair value range of $13.40 to $13.88. The stock's valuation (Forward PE: 9.1) is in line with its historical norms (9.1). At these levels, the market is pricing in 0.1% annual earnings growth.
Technical Outlook: Technically, INMD is in a downtrend. The price is currently testing key support at $13.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: INMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INMD is in a downtrend. The price is currently testing key support at $13.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: INMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.40 -
$13.88
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($14.33)
- BULLISH: Expecting earnings turnaround to 0.1% growth with 5.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$13.40 -
$13.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.25
Resistance Level
$13.69
Current Trend
Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.09
Wall Street Target
$14.33
(+8.5%)
Revenue Growth (YoY)
5.3%
Earnings Growth (YoY)
-30.8%
Profit Margin
23.3%
Valuation Premium vs History
+0.1% premium
PE vs Historical
9.1 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.1%
(market-implied from PE analysis)
1-Year Target
$13.22
(+0%)
2-Year Target
$13.24
(+0%)
3-Year Target
$13.25
(+0%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
$13.27
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.0%)
$42.13
(+219%)
Base:
(SPY PE: 9.1, Growth: 10.0%)
$17.58
(+33%)
Bear:
(PE: 7.7, Growth: 10.0%)
$14.94
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 9.93 | Current EPS (TTM): $1.35
Bull Case
$15.88
(+20%)
Analyst growth 7.7%, PE expands to 10.9
Base Case
$14.43
(+9%)
Market implied 7.7%, PE stable at 9.9
Bear Case
$9.11
(-31%)
Severe decline -20.0%, PE contracts to 8.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 10:13 AM ET
Data refreshes hourly during market hours. Next update: 11:13 AM
Data refreshes hourly during market hours. Next update: 11:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
